AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-226355260/roche-publishes-research-results.html" title="Facts and information about Roche publishes research results for Avastin: good and not so good news.">Roche publishes research results for Avastin: good and not so good news.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Roche publishes research results for Avastin: good and not so good news.
Roche Group published the most important results of a global phase III study on 23 Feb 2010 regarding the administration of the pharmaceutical Avastin (bevacizumab) in combination with Xeloda (capecitabin) or chemotherapy with Fluorouracil and Cisplatin in patients with inoperable, advanced or metastasising stomach cancer. The study AVAGAST failed is primary focus point, an extension of the total survival time for patients which were treated …
Related articles from newspapers, magazines, journals, and more
